Pulmonx Past Earnings Performance
Past criteria checks 0/6
Pulmonx's earnings have been declining at an average annual rate of -24.5%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 20.5% per year.
Key information
-24.5%
Earnings growth rate
58.7%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 20.5% |
| Return on equity | -51.4% |
| Net Margin | -88.6% |
| Next Earnings Update | 01 May 2024 |
Recent past performance updates
Recent updates
Pulmonx Corporation's (NASDAQ:LUNG) Share Price Matching Investor Opinion
Apr 04
Pulmonx: Revisiting Thesis Following Management Change
Mar 26Pulmonx (NASDAQ:LUNG) Has Debt But No Earnings; Should You Worry?
Feb 23Market Participants Recognise Pulmonx Corporation's (NASDAQ:LUNG) Revenues
Aug 01Analysts Just Shaved Their Pulmonx Corporation (NASDAQ:LUNG) Forecasts Dramatically
Nov 08Pulmonx GAAP EPS of -$0.40 in-line, revenue of $14M beats by $0.23M
Aug 02Pulmonx: Interesting Technology But Struggling With Adoption
Jul 02These Analysts Just Made A Meaningful Downgrade To Their Pulmonx Corporation (NASDAQ:LUNG) EPS Forecasts
Feb 28Earnings Update: Here's Why Analysts Just Lifted Their Pulmonx Corporation (NASDAQ:LUNG) Price Target To US$62.20
Mar 04Revenue & Expenses BreakdownBeta
How Pulmonx makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 69 | -61 | 95 | 18 |
| 30 Sep 23 | 65 | -61 | 92 | 18 |
| 30 Jun 23 | 61 | -61 | 88 | 18 |
| 31 Mar 23 | 57 | -59 | 86 | 16 |
| 31 Dec 22 | 54 | -59 | 83 | 15 |
| 30 Sep 22 | 52 | -58 | 80 | 15 |
| 30 Jun 22 | 52 | -54 | 77 | 14 |
| 31 Mar 22 | 50 | -52 | 74 | 14 |
| 31 Dec 21 | 48 | -49 | 70 | 13 |
| 30 Sep 21 | 45 | -45 | 65 | 12 |
| 30 Jun 21 | 42 | -39 | 59 | 11 |
| 31 Mar 21 | 33 | -38 | 52 | 9 |
| 31 Dec 20 | 33 | -32 | 46 | 7 |
| 30 Sep 20 | 33 | -28 | 42 | 7 |
| 30 Jun 20 | 32 | -28 | 40 | 6 |
| 31 Mar 20 | 35 | -22 | 37 | 6 |
| 31 Dec 19 | 33 | -21 | 34 | 6 |
| 31 Dec 18 | 20 | -18 | 20 | 7 |
Quality Earnings: LUNG is currently unprofitable.
Growing Profit Margin: LUNG is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LUNG is unprofitable, and losses have increased over the past 5 years at a rate of 24.5% per year.
Accelerating Growth: Unable to compare LUNG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LUNG is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: LUNG has a negative Return on Equity (-51.42%), as it is currently unprofitable.